Abbott | ABT - Ebitda


Abbott reported $2.43B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Agilent USD 577M 77M Jun/2026
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio-Rad Laboratories USD 595.3M 1.23B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Danaher USD 1.84B 81M Jun/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Pfizer USD 6.01B 18M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025
Solventum Corp USD 670M 233M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Terumo JPY 116.67B 58.79B Jun/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026